Wedge Capital Management L L P Gilead Sciences, Inc. Transaction History

Wedge Capital Management L L P

$5.45 Billion
Q3 2025

A detailed history of Wedge Capital Management L L P transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wedge Capital Management L L P holds 227,844 shares of GILD stock, worth $28.3 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

227,844

Previous 286,929 20.59%

Holding current value

$28.3 Million

Previous $31.8 Million 20.5%

% of portfolio

0.46%

Previous 0.59%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 10, 2025	SELL	$108.22 - $120.47 $6.39 Million - $7.12 Million	-59,085 Reduced 20.59%	227,844 $25.3 Million
Q2 2025 Jul 11, 2025	SELL	$96.91 - $113.0 $1.34 Million - $1.56 Million	-13,787 Reduced 4.58%	286,929 $31.8 Million
Q1 2025 Apr 14, 2025	SELL	$89.14 - $117.41 $1.12 Million - $1.47 Million	-12,509 Reduced 3.99%	300,716 $33.7 Million
Q4 2024 Jan 15, 2025	SELL	$83.95 - $97.9 $7.25 Million - $8.46 Million	-86,409 Reduced 21.62%	313,225 $28.9 Million
Q3 2024 Oct 11, 2024	BUY	$66.59 - $83.99 $26.6 Million - $33.6 Million	399,634 New	399,634 $33.5 Million
Q1 2022 Apr 12, 2022	SELL	$57.92 - $72.58 $28.5 Million - $35.7 Million	-492,307 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$64.88 - $73.64 $3.55 Million - $4.03 Million	54,756 Added 12.51%	492,307 $35.7 Million
Q3 2021 Oct 14, 2021	SELL	$67.69 - $73.03 $2.4 Million - $2.59 Million	-35,434 Reduced 7.49%	437,551 $30.6 Million
Q2 2021 Jul 14, 2021	SELL	$63.47 - $69.35 $579,671 - $633,373	-9,133 Reduced 1.89%	472,985 $32.6 Million
Q1 2021 Apr 12, 2021	BUY	$60.0 - $68.46 $28.9 Million - $33 Million	482,118 New	482,118 $31.2 Million
Q4 2020 Jan 08, 2021	SELL	$56.65 - $64.55 $24 Million - $27.4 Million	-423,873 Closed	0 $0
Q3 2020 Oct 08, 2020	SELL	$62.1 - $78.08 $1.37 Million - $1.72 Million	-22,057 Reduced 4.95%	423,873 $26.8 Million
Q2 2020 Jul 10, 2020	BUY	$72.34 - $84.0 $32.3 Million - $37.5 Million	445,930 New	445,930 $34.3 Million
Q1 2020 Apr 13, 2020	SELL	$62.63 - $80.22 $40.9 Million - $52.4 Million	-653,570 Closed	0 $0
Q4 2019 Jan 15, 2020	BUY	$61.62 - $67.78 $8.55 Million - $9.41 Million	138,778 Added 26.96%	653,570 $42.5 Million
Q3 2019 Nov 01, 2019	BUY	$62.51 - $69.0 $315,237 - $347,967	5,043 Added 0.99%	514,792 $32.6 Million
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $5.83 Million - $6.54 Million	-94,220 Reduced 15.6%	509,749 $34.4 Million
Q1 2019 May 02, 2019	BUY	$62.53 - $70.05 $6.79 Million - $7.6 Million	108,525 Added 21.9%	603,969 $39.3 Million
Q4 2018 Jan 31, 2019	BUY	$60.54 - $79.0 $1.26 Million - $1.65 Million	20,887 Added 4.4%	495,444 $31 Million
Q3 2018 Nov 01, 2018	BUY	$71.28 - $78.92 $33.8 Million - $37.5 Million	474,557 New	474,557 $36.6 Million
Q4 2017 Jan 31, 2018	SELL	$71.15 - $83.52 $38.1 Million - $44.7 Million	-535,474 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $38.6 Million - $45.8 Million	535,474	535,474 $43.4 Million

Others Institutions Holding GILD

# of Institutions

2,366

Shares Held

1.01B

Call Options Held

8.63M

Put Options Held

7.39M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.

Account

Wedge Capital Management L L P Gilead Sciences, Inc. Transaction History